3 trial readouts that could shake up the obesity market this year
PharmaVoice
JANUARY 8, 2025
A wave of new weight loss treatments is on the way, and drugmakers are scrambling for a foot in the door.
PharmaVoice
JANUARY 8, 2025
A wave of new weight loss treatments is on the way, and drugmakers are scrambling for a foot in the door.
MedCity News
JANUARY 8, 2025
Galapagos said the planned business separation will leave the legacy company free to focus on developing cell therapies for cancer. An accompanying corporate restructuring will shave Galapagoss headcount by 40%. The post Galapagos Keeps Focus on Cancer Cell Therapy, Spins Out Rest of Biz Into NewCo Backed by 2.4B appeared first on MedCity News.
pharmaphorum
JANUARY 8, 2025
Novo Nordisk almost doubles the scale of its R&D alliance with AI specialist Valo Health, which now spans 20 programmes and a value of up to $4.6bn.
MedCity News
JANUARY 8, 2025
Novo Nordisk and Valo Health have collaborated on the development of cardiovascular disease drugs since 2023. Expanding the alliance to cardiometabolic diseases nearly doubles the number of programs covered under the agreement. The post Novo Nordisk Adds Obesity and Diabetes to AI Drug Research Pact With Flagships Valo Health appeared first on MedCity News.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
PharmaTimes
JANUARY 8, 2025
Investment to support RNA therapeutics for epilepsy and neurological disorders
MedCity News
JANUARY 8, 2025
By grounding wellness programs in behavior-change science, employers can empower their people to build healthier, more sustainable habits. The post Study: Why Quick Fixes Dont Work in Workplace Wellness appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
JANUARY 8, 2025
When it comes to managing inbound phone calls, underperformance has devastating cost implications. The post What Keeps Healthcare CIOs Up at Night: Balancing Technology Investments with Consumer Expectations appeared first on MedCity News.
pharmaphorum
JANUARY 8, 2025
Clarivate has revealed 11 drugs due to launch in 2025 that could top $1 billion in annual sales or be clinical 'game changers' in the next five years.
MedCity News
JANUARY 8, 2025
Neuroflow acquired Intermountain Healths behavioral health risk analytics model to integrate into its software platform. The model identifies which patients may be at risk of experiencing mental health crises so that care teams can step in to provide timely support. The post Intermountain Health Sells Its Behavioral Health Risk Model to Neuroflow appeared first on MedCity News.
pharmaphorum
JANUARY 8, 2025
Rybrevant plus Lazcluze extended median OS by more than a year compared to Tagrisso in the MARIPOSA trial in treatment-naive, EGFR-mutated NSCLC
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
MedCity News
JANUARY 8, 2025
Certified clinicians and therapists have specific ethical foundations and analytic responsibilities to uphold that might not apply to all members of the healthcare field. The post Understanding the Ethics of AI in ABA Therapy appeared first on MedCity News.
pharmaphorum
JANUARY 8, 2025
Belgian biotech Galapagos is mixing things up again via a plan to split in two, separating its drug development and cell therapy operations.
Pharmaceutical Technology
JANUARY 8, 2025
GSK has gained US FDA breakthrough therapy designation for GSK'227 to treat adults with relapsed or refractory osteosarcoma.
MedCity News
JANUARY 8, 2025
Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things to look for include more widespread adoption of artificial intelligence technologies and the IPO markets return to normal levels. The post Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More appeared first on MedCity News.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PharmaTech
JANUARY 8, 2025
Vanessa Almendro, Elliot Berger, Benjamin McCloud, and Turna Ray go behind the headlinesto discuss 2024s biggest trends in the pharmaceutical industry, as well as the unforeseen outcomes that took us by surprise.
MedCity News
JANUARY 8, 2025
Transcarent is planning to acquire Accolade for $621 million, the companies announced Wednesday. The two companies are very complementary and the deal gives Accolade a chance to turn things around after struggling in the public market, experts say. The post Accolade Gets a Do-Over With Transcarent’s $621M Acquisition appeared first on MedCity News.
PharmaTech
JANUARY 8, 2025
The AI Lab was launched almost exactly three years ago and has produced several programs so far, at least one of which achieved its first scientific stage gate 40% faster than the teams originally forecasted.
Pharmaceutical Technology
JANUARY 8, 2025
As part of the agreement, Sanofi will provide Alloy with upfront license fees and near-term preclinical milestone payments up to $27.5m.
Quantified
JANUARY 8, 2025
Let’s face it planning a National Sales Meeting (NSM) for life sciences teams can feel like orchestrating a complex clinical trial. You need the right content, good time management, and strong execution. Our customers have been in your shoes, so we wanted to share some practical strategies to help you create an NSM that transforms your field teams’ capabilities.
Pharmaceutical Technology
JANUARY 8, 2025
China's National Medical Products Administration has granted expanded approval to MSD's GARDASIL for use in males aged nine to 26 years.
Pharmacy Times
JANUARY 8, 2025
Data from a follow-up at 6 months show a reduced risk of all-cause mortality in heart attack patients with anemia who receive a liberal transfusion strategy compared with a restrictive one.
Pharmaceutical Technology
JANUARY 8, 2025
Araris will use its linker technology to generate multi-warhead ADCs for undisclosed targets provided by Chugai.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharma Marketing Network
JANUARY 8, 2025
Reuters Pharma USA 2025 will unite senior pharma leaders across commercial, marketing, medical affairs, patient engagement, market access, real world evidence and data for two days of learnings in Philadelphia. The 2025 agenda is streamed by priority spotlighting use cases and tangible learnings across the key topic areas of customer engagement, tools and technology, value demonstration, and future proofing strategies.
Pharmaceutical Technology
JANUARY 8, 2025
Actuate Therapeutics has gained OMPD from the EMA for elraglusib aimed at treating pancreatic ductal adenocarcinoma (PDAC).
PharmExec
JANUARY 8, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
JANUARY 8, 2025
Orna will receive a $65m upfront payment and is eligible to receive potential milestone payments and royalties.
Advertiser: ZoomInfo
In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.
Pharmaceutical Commerce
JANUARY 8, 2025
What is the value in US adults addressing these risks, and how do social determinants of health play a role?
PharmExec
JANUARY 8, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
JANUARY 8, 2025
With clinical trials facing multiple challenges, digital solutions could provide the answer. We identify the key trends to watch in 2025.
Pharmaceutical Commerce
JANUARY 8, 2025
In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jon Kostas, executive director, Association for Prescription Psychedelics (APP), addresses the importance of stopping the spread of misinformation when it comes to psychedelics.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Let's personalize your content